Levetiracetam in pharma franchise in Punjab

Levetiracetam in PCD pharma franchise in Bhopal

Levetiracetam in top pharma company in Nashik

Levetiracetam in pcd pharma supplier in Rajkot

Levetiracetam in phama franchise company in India
Levetiracetam in phama distributor in Allahabad

Home/Products /levetiracetam-500mg-tablet

Lapcetam 500 Tablet

Composition : Levetiracetam (500mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹138.66/-

Lapcetam 500 Tablet is a medication in the antiepileptic therapy class, containing Levetiracetam (500 mg), which is used to manage various types of seizures in patients with epilepsy. It is effective in treating partial-onset seizures, generalized tonic-clonic seizures, and myoclonic seizures associated with juvenile myoclonic epilepsy. Lapcetam 500 Tablet works by modulating synaptic vesicle protein 2A, which helps stabilize brain activity and prevent the spread of abnormal electrical signals, reducing the occurrence of seizures.

This medication is suitable for use as both monotherapy and adjunctive therapy. It has minimal drug interaction potential, making it a safer choice for long-term management of epilepsy. By providing consistent seizure control, Lapcetam enhances the quality of life and helps patients regain confidence in their daily activities.

Lapcetam 500 Tablet offers a well-tolerated option for individuals with epilepsy, with most side effects being mild and manageable. It is essential to use this medication under medical supervision to ensure its effectiveness and safety.

Read More

About the Product

Lapcetam 500 Tablet is a medication in the antiepileptic therapy class, containing Levetiracetam (500 mg), which is used to manage various types of seizures in patients with epilepsy. It is effective in treating partial-onset seizures, generalized tonic-clonic seizures, and myoclonic seizures associated with juvenile myoclonic epilepsy. Lapcetam 500 Tablet works by modulating synaptic vesicle protein 2A, which helps stabilize brain activity and prevent the spread of abnormal electrical signals, reducing the occurrence of seizures.

This medication is suitable for use as both monotherapy and adjunctive therapy. It has minimal drug interaction potential, making it a safer choice for long-term management of epilepsy. By providing consistent seizure control, Lapcetam enhances the quality of life and helps patients regain confidence in their daily activities.

Lapcetam 500 Tablet offers a well-tolerated option for individuals with epilepsy, with most side effects being mild and manageable. It is essential to use this medication under medical supervision to ensure its effectiveness and safety.

Common side effects include drowsiness, fatigue, headache, dizziness, and irritability. In rare cases, behavioral changes, mood swings, or allergic reactions may occur.

Lapcetam 500 Tablet is indicated for managing partial-onset seizures, generalized tonic-clonic seizures, and myoclonic seizures in epilepsy.

This medication should be used under a healthcare professional's guidance. Do not stop taking it abruptly, as this may lead to withdrawal seizures. Follow the prescribed dosage and report any unusual symptoms to your doctor immediately.

Store at a temperature below 25°C in a cool, dry place, away from direct light and moisture. Keep out of the reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation